FromAstraZeneca ([email protected])
Subject (127)Datopotamab deruxtecan-based combinations show promising clinical activity in patients with advanced non-small cell lung cancer
Preheader (127)Datopotamab deruxtecan-based combinations show promising clinical activity in patients with advanced non-small cell lung cancer
Arial
Text Analysis
Body Words245
Subject Words15
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px860 px
X-Spam Score-4.6
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEarly Morning
